شمارش واحدهای کربوهیدرات در مبتلایان به دیابت نوع یک و اثر آن در کنترل وضعیت متابولیک: مقاله‌ی مروری
##plugins.themes.bootstrap3.article.main##
چکیده
مقدمه: با توجه به پاتوژنز بیماری دیابت و از طرف دیگر ضرورت استمرار درمان با استفاده از تزریق انسولین، به کارگیری روش‌هایی منطبق با سبک زندگی روزانه، مهم‌ترین گام برای کنترل مؤثر همراه با حفظ سلامت روحی و جسمی و تشویق افراد به پیگیری درمان می‌باشد. مطالعه‌ی حاضر با هدف بررسی تأثیر شمارش واحدهای کربوهیدرات در مبتلایان به دیابت نوع یک انجام شده است.
شیوه‌ی مطالعه: پژوهش حاضر یک مطالعه‌ی مروری است. جستجو با استفاده از کلید واژه‌ها از جمله دیابت نوع یک، دیابت نوع دو، انسولین و شمارش واحدهای کربوهیدرات به زبان فارسی و انگلیسی در پایگاه‌های معتبر از جمله PubMed، Wiley، Elsevier، Science Direct و SID از سال 2000 تا 2019 انجام شد و مقالات مورد بررسی قرار گرفتند.
نتیجه‌گیری: یافته‌ها نشان داد، جهت به کارگیری شمارش واحدهای کربوهیدرات، دو مفهوم باید در نظر گرفته شود. در گام نخست فاکتور حساسیت انسولین (قانون 1800 و قانون 1500) و در گام دوم، مفهوم دیگری به نام نسبت انسولین به کربوهیدرات (قانون 500، 450 و در کودکان قانون 300). در پایان میزان کل انسولین هدف، از مجموع انسولین مورد نیاز برای اصلاح گلوکز خون پیش از غذا و وعده‌ی غذایی به دست می‌آید. تنظیم میزان انسولین بر اساس میزان دریافت کربوهیدرات به کنترل بهتر وضعیت گلیسمیک، انعطاف‌پذیری الگوی تغذیه‌ای و بالا بردن کیفیت زندگی مؤثر است.
کلمات کلیدی: دیابت نوع یک، شمارش واحدهای کربوهیدرات، قانون 1800، قانون 500، انسولین
##plugins.themes.bootstrap3.article.details##
استناد به مقاله
خاراییف., کوه مناییش., محمدیم. ح., بیاتر., چراغیط., & دلیلیس. (2020). شمارش واحدهای کربوهیدرات در مبتلایان به دیابت نوع یک و اثر آن در کنترل وضعیت متابولیک: مقاله‌ی مروری. مجله دانشکده پزشکی زابل, 148-154. Retrieved از http://jzms.ir/index.php/JZMS/article/view/162
نوع مقاله
مقاله مروری
مراجع
1. Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 2017; 13(10): 572-87.
2. Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep 2016; 36(6). pii: e00416.
3. Bano G. Glucose homeostasis, obesity and diabetes. Best Pract Res Clin Obstet Gynaecol 2013; 27(5): 715-26.
4. Sanusi H. The role of incretin on diabetes mellitus. Acta Med Indones 2009; 41(4): 205-12.
5. Tofteng AP, Jensen KJ, Schäffer L, Hoeg-Jensen T. Total synthesis of desB30 insulin analogues by biomimetic folding of single‐chain precursors. Chembiochem 2008; 9(18): 2989-96.
6. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 2011; 93 (Suppl 1): S52-9.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62-S69.
8. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
9. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells. Diabetes 2010; 59(4): 978-86.
10. Kondrashova A, Hyöty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes. Int Rev Immunol 2014; 33(4): 284-95.
11. Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 2011; 27(1): 3-13.
12. Hogg-Kollars S, Al Dulaimi D, Tait K, Rostami K. Type 1 diabetes mellitus and gluten induced disorders. Gastroenterol Hepatol Bed Bench 2014; 7(4): 189-97.
13. Berridge MJ. Vitamin D deficiency and diabetes. Biochem J 2017; 474(8):1321-32.
14. Hyöty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002; 45(10): 1535-61.
15. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2018; 42 (Suppl 1): S10-S15.
16. Shabani R, Nazari M, Dalili S, Hasanzadeh Rad A. Effect of circuit resistance training on glycemic control of females with diabetes Type II. Int J Prev Med 2015; 6: 34.
17. Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2009; 10(Suppl 12): 82-99.
18. Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab 2006; 8(1): 26-30.
19. Malik FS, Taplin CE. Insulin therapy in children and adolescents with type 1 diabetes. Pediatric Drugs 2014; 16(2): 141-50.
20. Gerich JE. Insulin glargine: long-acting basal insulin analog for improved metabolic control. Curr Med Res Opin 2004; 20(1): 31-7.
21. Kliegman RM, Stanton B, Geme J, Schor NF. Nelson textbook of pediatrics. Amsterdam, Netherlands: Elsevier Health Sciences; 2015. p. 2770-7.
22. Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care 2004; 27(9): 2266-71.
23. Trumbo P, Schlicker S, Yates AA, Poos M, Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohdrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J J Am Diet Assoc 2002; 102(11): 1621-30.
24. Tascini G, Berioli M, Cerquiglini L, Santi E, Mancini G, Rogari F, et al. Carbohydrate counting in children and adolescents with type 1 diabetes. Nutrients 2018; 10(1): 109.
25. Souto DL, Rosado EL. Use of carb counting in the dietary treatment of diabetes mellitus. Nutr Hosp 2010; 25(1): 18-25.
26. Spiegel G, Penkilo M. Carbohydrate counting for children with diabetes: Why, what and how? School Nurse News 2008; 25(4): 36-8.
27. Laurenzi A, Bolla AM, Panigoni G, Doria V, Uccellatore A, Peretti E, et al. Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR). Diabetes Care 2011; 34(4): 823-7.
28. Dias VM, Pandini JA, Nunes RR, Sperandei SL, Portella ES, Cobas RA, et al. Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes. Diabetol Metab Syndr 2010; 2: 54.
29. Son O, Efe B, Son NE, Akalin A, Kebapçi N. Investigation on carbohydrate counting method in type 1 diabetic patients. BioMed Research International 2014; 2014.
30. Pearson KK, Reiland SA, Meara JG, Brown JK, Fedraw LA, Mapes DL. Improving glycemic control and insulin ordering efficiency for hospitalized patients with diabetes through carbohydrate counting. J Healthc Qual 2016; 38(1): e1-9.
2. Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep 2016; 36(6). pii: e00416.
3. Bano G. Glucose homeostasis, obesity and diabetes. Best Pract Res Clin Obstet Gynaecol 2013; 27(5): 715-26.
4. Sanusi H. The role of incretin on diabetes mellitus. Acta Med Indones 2009; 41(4): 205-12.
5. Tofteng AP, Jensen KJ, Schäffer L, Hoeg-Jensen T. Total synthesis of desB30 insulin analogues by biomimetic folding of single‐chain precursors. Chembiochem 2008; 9(18): 2989-96.
6. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 2011; 93 (Suppl 1): S52-9.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62-S69.
8. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
9. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells. Diabetes 2010; 59(4): 978-86.
10. Kondrashova A, Hyöty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes. Int Rev Immunol 2014; 33(4): 284-95.
11. Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 2011; 27(1): 3-13.
12. Hogg-Kollars S, Al Dulaimi D, Tait K, Rostami K. Type 1 diabetes mellitus and gluten induced disorders. Gastroenterol Hepatol Bed Bench 2014; 7(4): 189-97.
13. Berridge MJ. Vitamin D deficiency and diabetes. Biochem J 2017; 474(8):1321-32.
14. Hyöty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002; 45(10): 1535-61.
15. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2018; 42 (Suppl 1): S10-S15.
16. Shabani R, Nazari M, Dalili S, Hasanzadeh Rad A. Effect of circuit resistance training on glycemic control of females with diabetes Type II. Int J Prev Med 2015; 6: 34.
17. Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2009; 10(Suppl 12): 82-99.
18. Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab 2006; 8(1): 26-30.
19. Malik FS, Taplin CE. Insulin therapy in children and adolescents with type 1 diabetes. Pediatric Drugs 2014; 16(2): 141-50.
20. Gerich JE. Insulin glargine: long-acting basal insulin analog for improved metabolic control. Curr Med Res Opin 2004; 20(1): 31-7.
21. Kliegman RM, Stanton B, Geme J, Schor NF. Nelson textbook of pediatrics. Amsterdam, Netherlands: Elsevier Health Sciences; 2015. p. 2770-7.
22. Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care 2004; 27(9): 2266-71.
23. Trumbo P, Schlicker S, Yates AA, Poos M, Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohdrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J J Am Diet Assoc 2002; 102(11): 1621-30.
24. Tascini G, Berioli M, Cerquiglini L, Santi E, Mancini G, Rogari F, et al. Carbohydrate counting in children and adolescents with type 1 diabetes. Nutrients 2018; 10(1): 109.
25. Souto DL, Rosado EL. Use of carb counting in the dietary treatment of diabetes mellitus. Nutr Hosp 2010; 25(1): 18-25.
26. Spiegel G, Penkilo M. Carbohydrate counting for children with diabetes: Why, what and how? School Nurse News 2008; 25(4): 36-8.
27. Laurenzi A, Bolla AM, Panigoni G, Doria V, Uccellatore A, Peretti E, et al. Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR). Diabetes Care 2011; 34(4): 823-7.
28. Dias VM, Pandini JA, Nunes RR, Sperandei SL, Portella ES, Cobas RA, et al. Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes. Diabetol Metab Syndr 2010; 2: 54.
29. Son O, Efe B, Son NE, Akalin A, Kebapçi N. Investigation on carbohydrate counting method in type 1 diabetic patients. BioMed Research International 2014; 2014.
30. Pearson KK, Reiland SA, Meara JG, Brown JK, Fedraw LA, Mapes DL. Improving glycemic control and insulin ordering efficiency for hospitalized patients with diabetes through carbohydrate counting. J Healthc Qual 2016; 38(1): e1-9.